Navigation Links
Cancer risk among nuclear industry workers

A cohort multinational study was done involving 598 068 nuclear industry workers from 15 countries.// The study was done to estimate the risk of cancer after administrating low doses of radiation.

This study is an international collaborative study to estimate the cancer risk among radiation workers in the nuclear industry to find out the risk of cancer occurrence after low dose exposure of radiation.

The study recruits were employed in 154 different facilities, involved in nuclear power production, research, waste management and industries of fuel, isotope and weapon. During the study period, about 24,158 (5.9%) of recruits died, 6519 from cancer other than leukaemia and 196 from leukaemia (excluding lymphocytic leukaemia).

Results from the study show that there is an increased risk of cancer exists in the recruits even at a low dose and a significant increase risk for all cancers (excluding leukaemia). Some factors like smoking and diet in recruits can have an association between radiation dose and risk of cancer. Some earlier studies have found associations between radiation dose and smoking and while others have not. Factors such as smoking can confound the association between radiation doses and risk only if they are related both to risk of cancer and to dose.

Current recommendations form the International Commission on Radiological Protection (ICRP) are to limit occupational doses to 100 Sv (sieverts) over five years (not to exceed 50 Sv in any one year) and doses to the public to 1 Sv per year. This study results show that an exposure of 100 Sv will cause 9.7% mortality from cancer (excluding leukaemia), and a 5.9% increased mortality from cancers excluding leukaemia, lung, and pleura.

Our study is the largest study on nuclear industry workers conducted so far, and provides an estimation of radiation risk. These results suggest that there is an increased risk of cancer occurs even at a lower dose of nucle ar radiation.


'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
(Date:5/26/2016)... ... 26, 2016 , ... American orthopedic surgeon and internationally recognized ... Horizon International (BHI), Brian Mehling, M.D., spoke at an International Conference and Expo ... in Chicago, IL, USA. Dr. Mehling’s presentation was focused on stem cell therapy ...
(Date:5/26/2016)... TN (PRWEB) , ... May 26, 2016 , ... ... fitness education and products recently hosted the first PowerWave Instructor Certification Course in ... who lead a group of fitness professional through the 8 hour interactive course ...
(Date:5/26/2016)... ... 2016 , ... On May 23rd during the National Eye Institute’s “Healthy Vision ... advocate, was honored by Ashram, Inc. as the world’s foremost water visionary. , “Sharon ... banks of the Nile to fill their red clay pots with life-sustaining water.” Said ...
(Date:5/26/2016)... ... May 26, 2016 , ... Workrite Ergonomics ... leadership and to further develop their rapidly expanding portfolio of customer and end ... a concentration in Marketing and an M.B.A. with concentration in management from Bryant ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... , May 26, 2016 ... Associated With Both Cost Savings and Overall ... plc (LSE: BTG), an international specialist healthcare company, ... at the 21st Annual Meeting of ISPOR (International ... treatment of hepatocellular carcinoma (HCC) using yttrium-90 glass ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 /PRNewswire/ ... Frankfurt Prime Standard: QIA) today announced that the company has ... GmbH to develop and commercialize predictive assays in oncology. An ... a marker to predict effectiveness of anthracycline treatment in triple ... are pleased to partner with Therawis, which developed the PITX2 ...
Breaking Medicine Technology: